FigureĀ 2.
Recurrently mutated genes and mutation burden observed for all patients. The bar graph on the top corresponds to the number of total mutations per patient and is colored by mutation type. The bar graph on the left corresponds to the percentage of mutations for a given gene for the entire cohort. Columns represent each sample in the cohort (1 patient, LYM120, with both tumor [t] and relapse [r] samples is shown) and are ordered by the presence of mutations in the most to least frequently mutated gene. The third plot indicates the presence or absence of a mutation for each patient and gene combination, colored by mutation type. If a patient has multiple mutations for an individual gene, it is colored according to the priority order as indicated in the mutation type legend, from top to bottom. A white star indicates which mutations are predicted to result in high-quality neoantigen vaccine candidates.

Recurrently mutated genes and mutation burden observed for all patients. The bar graph on the top corresponds to the number of total mutations per patient and is colored by mutation type. The bar graph on the left corresponds to the percentage of mutations for a given gene for the entire cohort. Columns represent each sample in the cohort (1 patient, LYM120, with both tumor [t] and relapse [r] samples is shown) and are ordered by the presence of mutations in the most to least frequently mutated gene. The third plot indicates the presence or absence of a mutation for each patient and gene combination, colored by mutation type. If a patient has multiple mutations for an individual gene, it is colored according to the priority order as indicated in the mutation type legend, from top to bottom. A white star indicates which mutations are predicted to result in high-quality neoantigen vaccine candidates.

Close Modal

or Create an Account

Close Modal
Close Modal